Search

Your search keyword '"Halai, D"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Halai, D" Remove constraint Author: "Halai, D"
43 results on '"Halai, D"'

Search Results

1. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

2. Expanding SPTAN1 monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia

3. Identification of 4 novel human ocular coloboma genes ANK3, BMPR1B, PDGFRA, and CDH4 through evolutionary conserved vertebrate gene analysis

4. Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly and define a novel laminopathy

5. DYNC2H1 hypomorphic or retina-predominant variants cause nonsyndromic retinal degeneration

6. De Novo SOX6 Variants Cause a Neurodevelopmental Syndrome Associated with ADHD, Craniosynostosis, and Osteochondromas

7. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

8. Expanding SPTAN1 monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia

9. Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy

10. Genotype–phenotype correlations for COL4A3–COL4A5 variants resulting in Gly substitutions in Alport syndrome

11. Identification of 4 novel human ocular coloboma genes ANK3, BMPR1B, PDGFRA, and CDH4 through evolutionary conserved vertebrate gene analysis

12. Human and mouse essentiality screens as a resource for disease gene discovery

13. Expanding SPTAN1monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia

14. De Novo SOX6 Variants Cause a Neurodevelopmental Syndrome Associated with ADHD, Craniosynostosis, and Osteochondromas

15. Heterozygous UCHL1loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy

16. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli

17. Identification of 4 novel human ocular coloboma genes ANK3, BMPR1B, PDGFRA, and CDH4through evolutionary conserved vertebrate gene analysis

18. Biallelic CRELD1variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

22. Genome-wide association study identifies two susceptibility loci for osteosarcoma

24. MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.

25. Corrigendum: Opportunities and Challenges for Molecular Understanding of Ciliopathies–The 100,000 Genomes Project.

26. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types

27. The 100 000 Genomes Project: bringing whole genome sequencing to the NHS.

28. A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.

29. Recurrent PTPRB and PLCG1 mutations in angiosarcoma.

30. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

31. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.

32. Genome-wide association study identifies two susceptibility loci for osteosarcoma.

34. Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.

35. A common single-nucleotide variant in T is strongly associated with chordoma.

36. An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.

37. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.

38. Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes.

39. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.

40. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.

41. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.

42. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.

43. Primary myxoid liposarcoma of the ovary in an adolescent girl: a case report.

Catalog

Books, media, physical & digital resources